Search bioRxivSearch

Biology subjects

Sieberts, S.

Publications and source records attributed to Sieberts, S..

2 recordsLinked to original sources

Functional annotation of rare structural variation in the human brain

Structural variants (SVs) contribute substantially to risk of many brain related disorders including autism and schizophrenia. However, annotating the potential contribution of SVs to disease remains a major challenge. Here, we integrated high resolution SV calling from genome-sequencing in 755 human post-mortem brains with dorsal lateral prefrontal cortex RNA-sequencing from a subset of 629 samples to quantify the dosage and regulatory effects of SVs. We show that genic (p = 5.44x10-9) and regulatory SVs (enhancer p = 3.22x10-23, CTCF p = 3.86x10-18) are present at significantly lower frequencies than intergenic SVs after correcting for SV length. Copy number variants (CNVs)--deletions and duplications--exhibit a significant quantitative and directional relationship between the proportion of genic and regulatory content altered and gene expression, and the size of the effect is inversely correlated with the loss-of-function intolerance of the gene. We trained a joint linear model that leverages genic and regulatory annotations to predict expression effects of rare CNVs in independent samples (R2 = 0.21-0.41). We further developed a regulatory disruption score for each CNV that aggregates the predicted expression across all affected genes weighted by the genes intolerance score and applied it to an independent set of SVs from 14,891 genome-sequenced individuals. Pathogenic deletions implicated in neurodevelopmental disorders by ClinGen had significantly more extreme regulatory disruption scores than the rest of the SVs. Rank ordering based on the most extreme regulatory disruption scores prioritized pathogenic deletions that would not have been prioritized by frequency or length alone. This work points to the deleteriousness of regulatory SVs, particularly those altering CTCF sites. We further provide a simple approach for functionally annotating the regulatory effects of SVs in the human brain that has potential to be useful in larger SV studies and should improve as more regulatory annotation data is generated.

genomics

Identifying and ranking potential driver genes of Alzheimer's Disease using multi-view evidence aggregation

MotivationLate onset Alzheimers disease (LOAD) is currently a disease with no known effective treatment options. To address this, there have been a recent surge in the generation of multi-modality data (Hodes and Buckholtz, 2016; Mueller et al., 2005) to understand the biology of the disease and potential drivers that causally regulate it. However, most analytic studies using these data-sets focus on uni-modal analysis of the data. Here we propose a data-driven approach to integrate multiple data types and analytic outcomes to aggregate evidences to support the hypothesis that a gene is a genetic driver of the disease. The main algorithmic contributions of our paper are: i) A general machine learning framework to learn the key characteristics of a few known driver genes from multiple feature-sets and identifying other potential driver genes which have similar feature representations, and ii) A flexible ranking scheme with the ability to integrate external validation in the form of Genome Wide Association Study (GWAS) summary statistics. While we currently focus on demonstrating the effectiveness of the approach using different analytic outcomes from RNA-Seq studies, this method is easily generalizable to other data modalities and analysis types. ResultsWe demonstrate the utility of our machine learning algorithm on two benchmark multi-view datasets by significantly outperforming the baseline approaches in predicting missing labels. We then use the algorithm to predict and rank potential drivers of Alzheimers. We show that our ranked genes show a significant enrichment for SNPs associated with Alzheimers, and are enriched in pathways that have been previously associated with the disease. AvailabilitySource code and link to all feature sets is availabile at https://github.com/Sage-Bionetworks/EvidenceAggregatedDriverRanking. Contactben.logsdon@sagebionetworks.org

bioinformatics